EDGAR Filing Documents for 0000950123-11-063684

Form 8-K - Current report:

SEC Accession No. 0000950123-11-063684

Filing Date

2011-07-01

Accepted

2011-07-01 16:11:06

Documents

Period of Report

2011-06-30

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	c19538e8vk.htm	8-K	17650
2	EXHIBIT 1.1	c19538exv1w1.htm	EX-1.1	129581
3	EXHIBIT 4.1	c19538exv4w1.htm	EX-4.1	55166
4	EXHIBIT 5.1	c19538exv5w1.htm	EX-5.1	11111
5	EXHIBIT 99.1	c19538exv99w1.htm	EX-99.1	9610
6	GRAPHIC	c19538c1953801.gif	GRAPHIC	2952
7	GRAPHIC	c19538c1953800.gif	GRAPHIC	6055
	Complete submission text file	0000950123-11-063684.txt		237110

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922

Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330

Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)